IP Library Granted Patent US 12,102,714
Granted Patent B2
US 12,102,714 · App. 17/342,807 · Granted Oct 1, 2024

Disintegrating oral tablet suitable for active pharmaceutical ingredients

Inventor: Helle Wittorff (Vejle Ost, DK)
Assignee: Fertin Pharma A/S
A61K9/0056A61K9/2018A61K9/2086A61K9/2095
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,102,714
App. No.
17/342,807
Granted
Oct 1, 2024
Kind
B2
Abstract

A disintegrating oral tablet suitable for active pharmaceutical ingredients includes a population of particles and at least one flavor ingredient. The population of particles includes directly compressible (DC) and non-directly compressible (non-DC) sugar alcohol particles, the non-DC particles providing the tablet with a plurality of discrete non-DC areas, and the non-DC areas resulting in a burst of the at least one flavor ingredient upon mastication of the tablet.

Claims (22)

1. A disintegrating oral direct compression tablet suitable for active ingredients comprising a population of particles and at least one flavor ingredient in an amount of 1-10% by weight of the tablet, the population of particles comprising a) non-directly compressible (non-DC) sugar alcohol particles consisting essentially of pure sugar alcohol and b) particles comprising gum base, the non-DC particles providing the direct compression tablet with a plurality of discrete non-DC areas formed by single non-DC sugar alcohol particles or small groups of non-DC sugar alcohol particles, the at least one flavor ingredient being dispersed within the direct compression tablet in a matrix comprising the non-DC areas, and the non-DC areas resulting in a burst of the at least one flavor ingredient upon mastication of the tablet.

2. The oral tablet according to claim 1 , wherein the tablet is designed to release at least 50% by weight of the at least one flavor ingredient within 20 seconds from onset of mastication.

3. An oral tablet suitable for active ingredients comprising a population of particles and at least one flavor ingredient, the population of particles comprising a) non-directly compressible (non-DC) sugar alcohol particles and b) particles comprising gum base, the non-DC particles consisting essentially of pure sugar alcohol, the at least one flavor ingredient being dispersed within the oral tablet in a matrix comprising the non-DC particles.

4. The oral tablet according to claim 3 , wherein the non-DC sugar alcohol particles are selected from non-DC particles of erythritol, maltitol, mannitol, xylitol, lactitol, isomalt, and combinations thereof.

5. The oral tablet according to claim 3 , wherein the tablet comprises said non-DC sugar alcohol particles in an amount of at least 10% by weight of the tablet.

6. The oral tablet according to claim 3 , wherein the population of particles further comprises c) directly compressible (DC) sugar alcohol particles, and the tablet has a weight ratio between said non-DC sugar alcohol particles and said DC sugar alcohol particles, which is between 0.3 and 0.7.

7. The oral tablet according to claim 3 , wherein the population of particles further comprises c) directly compressible (DC) sugar alcohol particles, and the non-DC particles have an average non-DC particle size at least 50 μm larger than an average DC particle size of the DC particles.

8. The oral tablet according to claim 3 , wherein at least 30% by weight of the non-DC sugar alcohol particles have a particles size above 500 μm.

9. The oral tablet according to claim 3 , wherein the tablet comprises active pharmaceutical ingredients.

10. The oral tablet according to claim 3 , wherein the tablet is designed to be masticated into a coherent residual containing water-insoluble components.

11. The oral tablet according to claim 3 , wherein the gum base comprises at least 5% by weight of elastomer.

12. The oral tablet according to claim 3 , wherein the tablet comprises a first module comprising a), b), and at least a portion of the at least one flavor ingredient.

13. The oral tablet according to claim 3 , wherein the tablet comprises a first module comprising a), b), and at least a portion of the at least one flavor ingredient, and a second module comprising a second population of particles.

14. The oral tablet according to claim 3 , wherein the tablet comprises a first module comprising a), and a second module comprising b), the first module comprising at least a portion of the at least one flavor ingredient.

15. The oral tablet according to claim 3 , wherein the tablet comprises a first module comprising a), and a second module comprising b) and c) directly compressible (DC) sugar alcohol particles, the first module comprising at least a portion of the at least one flavor ingredient.

16. The oral tablet according to claim 3 , wherein the tablet comprises a first module comprising a) in an amount of at least 10% by weight of the tablet, and a second module comprising b) in an amount of 20 to 80% by weight of the tablet and c) directly compressible (DC) sugar alcohol particles in an amount of at least 10% by weight of the tablet, the first module comprising at least a portion of the at least one flavor ingredient.

17. The oral tablet according to claim 3 , wherein the tablet comprises a first module comprising a) and c) directly compressible (DC) sugar alcohol particles, and a second module comprising b), the first module comprising at least a portion of the at least one flavor ingredient.

18. The oral tablet according to claim 3 , wherein the tablet comprises a first module comprising a) in an amount of at least 10% by weight of the tablet and c) directly compressible (DC) sugar alcohol particles in an amount of at least 10% by weight of the tablet, and a second module comprising b) in an amount of 20 to 80% by weight of the tablet, the first module comprising at least a portion of the at least one flavor ingredient.

19. An oral tablet suitable for active ingredients comprising a population of particles and at least one flavor ingredient, the population of particles comprising non-directly compressible (non-DC) sugar alcohol particles and one or more directly compressible (DC) components, the non-DC particles consisting essentially of pure sugar alcohol, the at least one flavor ingredient being dispersed within the oral tablet in a matrix comprising the non-DC particles.

20. The oral tablet according to claim 19 , wherein the one or more directly compressible (DC) components are present in an amount of at least 10% by weight of the tablet.

21. The oral tablet according to claim 19 , wherein the one or more directly compressible (DC) components comprise an active pharmaceutical ingredient.

22. The oral tablet according to claim 19 , wherein the one or more directly compressible (DC) components comprise calcium carbonate.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 25, 2021
From: WITTORFF, HELLE
To: FERTIN PHARMA A/S
Reel/Frame 056671/0240 →
Continuity (2)
Continuation 15982556 · May 17, 2018
Related Publication 20210290530A1 · Sep 23, 2021